KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EBIT Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 337.00
Dec 31, 2025 114.00
Sep 30, 2025 -250.00
Jun 30, 2025 1,448.00
Mar 31, 2025 -1,098.00
Dec 31, 2024 136.00
Sep 30, 2024 132.00
Jun 30, 2024 945.00
Mar 31, 2024 -220.00
Dec 31, 2023 -1,377.00
Sep 30, 2023 -914.00
Jun 30, 2023 695.00
Mar 31, 2023 -45,437.00
Dec 31, 2022 44,585.00
Sep 30, 2022 699.00
Jun 30, 2022 -708.00
Mar 31, 2022 642.00
Dec 31, 2021 -181.00
Sep 30, 2021 2,277.00
Jun 30, 2021 -2,339.00
Mar 31, 2021 438.00
Dec 31, 2020 -649.00
Sep 30, 2020 76.00
Jun 30, 2020 -79.00
Mar 31, 2020 340.00
Dec 31, 2019 -1,050.00
Sep 30, 2019 -272.00
Jun 30, 2019 128.00
Mar 31, 2019 707.00
Dec 31, 2018 -247.00
Sep 30, 2018 -771.00
Jun 30, 2018 -115.00
Mar 31, 2018 1,071.00
Dec 31, 2017 -442.00
Sep 30, 2017 -368.00
Jun 30, 2017 -143.00
Mar 31, 2017 596.00
Dec 31, 2016 -193.00
Sep 30, 2016 233.00
Jun 30, 2016 -237.00
Mar 31, 2016 770.00
Dec 31, 2015 -425.00
Sep 30, 2015 267.00
Jun 30, 2015 -175.00
Mar 31, 2015 1,329.00
Dec 31, 2014 -204.00
Sep 30, 2014 -819.00
Jun 30, 2014 712.00
Mar 31, 2014 658.00
Dec 31, 2013 -1,159.00
Sep 30, 2013 259.00
Jun 30, 2013 -101.00
Mar 31, 2013 965.00
Dec 31, 2012 -879.00
Sep 30, 2012 -396.00
Jun 30, 2012 -3.00
Mar 31, 2012 812.00
Dec 31, 2011 1,620.00
Sep 30, 2011 -2,067.00
Jun 30, 2011 -152.00
Mar 31, 2011 733.00
Dec 31, 2010 -1,094.00
Sep 30, 2010 -264.00
Jun 30, 2010 1.00
Mar 31, 2010 1,198.00
Dec 31, 2009 -1,296.00
Sep 30, 2009 287.00
Jun 30, 2009 -70.00